Metformin Orifarm

Metformin Hydrochloride, the active ingredient in Metformin Orifarm, is a biguanide presented as an oral tablet for oral use. It is used to lower blood glucose levels in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Orifarm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Orifarm belongs to the biguanide class and is used to improve glycaemic control in disorders of glucose metabolism.

- Type 2 diabetes mellitus: lowers fasting and post‑prandial blood glucose by improving insulin sensitivity. - Prediabetes: may delay progression to overt diabetes by reducing hepatic glucose output. - Polycystic ovary syndrome (PCOS): helps restore ovulatory cycles by decreasing insulin resistance.

Metformin Orifarm may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastro‑intestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhoea: watery stools occurring especially after dose initiation. - Metallic taste: transient alteration in taste perception. - Weight loss: modest reduction in body weight in some patients.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening accumulation of lactate, especially in renal impairment. - Severe skin reactions: such as Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic dysfunction: marked elevation of liver enzymes or hepatitis.

Metformin Orifarm requires careful monitoring and specific safety measures before and during therapy. - Renal function assessment: avoid use in patients with severe renal impairment (eGFR <30 mL/min/1.73 m²). - Hepatic disease caution: monitor liver enzymes in patients with existing liver disease. - Lactic acidosis risk: discontinue before any radiographic contrast studies that may affect kidney function. - Pregnancy safety: classified as Category B; use only if clearly needed. - Contraindication: do not use in patients with known hypersensitivity to metformin. - Store at room temperature: keep in the original container, protect from moisture and heat.

Metformin Orifarm can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Alcohol: increases risk of lactic acidosis, especially with chronic intake. - Iodinated contrast agents: may precipitate acute renal failure, requiring temporary discontinuation.

Moderate Interactions (Monitor Closely): - Cimetidine: can raise metformin plasma concentrations, necessitating dose adjustment. - ACE inhibitors or ARBs: may affect renal function, requiring periodic monitoring. - Other antidiabetic agents (e.g., sulfonylureas, insulin): increase risk of hypoglycaemia, so glucose levels should be closely watched.